There is a growing need to support recovery from neurological and psychological conditions in both civilian healthcare and the military. Stroke, depression, PTSD and traumatic brain injury (TBI) affect millions of people, including soldiers exposed to high operational stress. Traditional rehabilitation is slow, resource-intensive and often insufficient.
QVITI develops and deploys non-invasive neuromodulation (tES) and neurorehabilitation solutions that enhance neuroplasticity, enabling faster and more effective recovery.
These technologies have a dual-use role:
- Civilian: post-stroke and aphasia rehabilitation, depression, cognitive dysfunction.
- Military: recovery after TBI and PTSD, reduction of phantom pain, and cognitive resilience training for high-load operators (e.g., drone/ISR units).
The project is already in implementation:
- clinical deployments in Poland,
- FDA-pathway research with U.S. centers,
- introduction in a leading military medical hospital,
- collaboration within dual-use and life science clusters.
Goal: create a scalable neurotechnology model that strengthens both national defense readiness and public health.


